Crizotinib in ROS1 and MET Deregulated NSCLC-Letter

Clin Cancer Res. 2020 Apr 1;26(7):1774. doi: 10.1158/1078-0432.CCR-19-3740.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Non-Small-Cell Lung*
  • Crizotinib
  • Humans
  • Lung Neoplasms*
  • Prospective Studies
  • Protein Kinase Inhibitors
  • Protein-Tyrosine Kinases
  • Proto-Oncogene Proteins

Substances

  • Protein Kinase Inhibitors
  • Proto-Oncogene Proteins
  • Crizotinib
  • Protein-Tyrosine Kinases
  • ROS1 protein, human